Xtant Medical Holdings Inc

For the period ended Dec 31, 2023. Filed Apr 1, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Apr 1, 2024

XTNT$0.28-3.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	XTANT MEDICAL HOLDINGS, INC.
April 1, 2024	By:	/s/ Sean E. Browne
	Name:	Sean E. Browne
	Title:	President and Chief Executive Officer (principal executive officer)
	By:	/s/ Scott C. Neils
	Name:	Scott C. Neils
	Title:	Chief Financial Officer (principal financial and accounting officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on April 1, 2024.

John K. Bakewell
Signature	Title
/s/ Sean E. Browne	President and Chief Executive Officer
Sean E. Browne	(principal executive officer)
/s/ Scott C. Neils	Chief Financial Officer
Scott C. Neils	(principal financial and accounting officer)
/s/ John K. Bakewell	Director
/s/ Jonn R. Beeson	Director
Jonn R. Beeson
/s/ Robert E. McNamara	Director
Robert E. McNamara
/s/ Lori D. Mitchell-Keller	Director
Lori D. Mitchell-Keller
/s/ Stavros G. Vizirgianakis	Director
Stavros G. Vizirgianakis

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.